Immune Cells at Injury Sites Release Opioid Peptides That Naturally Control Inflammatory Pain | Research

The takeaway

Immune cells infiltrating inflamed tissue release met-enkephalin and dynorphin A (in addition to previously known beta-endorphin), providing a local opioid pain control system at sites of inflammation.

3 local painkillers
Immune cells release met-enkephalin, dynorphin A, and beta-endorphin directly at inflammation sites for targeted, local pain control

What the researchers found

Immune cells at sites of inflammation contain and release met-enkephalin, dynorphin A, and beta-endorphin, which activate peripheral opioid receptors on sensory nerves to provide local inflammatory pain control.

Why it matters

Local pain control by immune cells avoids the side effects of brain-acting painkillers. Enhancing this natural peripheral opioid system could provide effective pain relief without sedation, addiction, or respiratory depression.

How the study worked

Animal study in rats with CFA-induced paw inflammation. Immune cells from inflamed tissue tested for opioid peptide content (RIA) and release (stimulation assays). Pain behavior correlated with local opioid receptor activation.

What this study cannot tell us

Rat inflammation model. The quantity of opioid released may not be sufficient for complete pain control. Human immune cell opioid release may differ quantitatively.

How to read the evidence

Moderate evidence from a well-designed inflammatory pain model with specific peptide quantification and functional pain behavior correlation.

When this study was published

Published in 2001. Peripheral immune cell opioid release is now recognized as a key component of inflammatory pain regulation.

The bigger picture

The immune system doesn't just cause pain through inflammation — it also provides pain relief through local opioid release. This elegant self-regulating system could be harnessed for novel pain treatments.

Questions still open

Can immune cell opioid release be pharmacologically enhanced for pain management?
Do anti-inflammatory drugs interfere with this natural pain control?
Is this mechanism impaired in chronic pain conditions?

Common questions

Do your immune cells make painkillers?

Yes. When immune cells arrive at an inflammation site, they release the same natural opioid peptides found in the brain — but locally at the site of pain, providing targeted relief without brain-related side effects.

Could this be used for better pain treatment?

Yes. Drugs that boost this local opioid release could control pain at its source without the sedation, addiction, and respiratory risks of conventional opioids. This is an active area of pain research.

Read the original research

Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain.

Pain, 93(3), 207-212

View on PubMed ↗Publisher’s paper ↗

Citation

Cabot, Peter J; Carter, Laurenda; Schäfer, Michael; Stein, Christoph. (2001). Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain.. Pain, 93(3), 207-212. https://doi.org/10.1016/S0304-3959(01)00322-0